Cargando…
Clozapine-Induced Late Agranulocytosis and Severe Neutropenia Complicated with Streptococcus pneumonia, Venous Thromboembolism, and Allergic Vasculitis in Treatment-Resistant Female Psychosis
Clozapine is a second-generation antipsychotic agent from the benzodiazepine group indicated for treatment-resistant schizophrenia and other psychotic conditions. Using clozapine earlier on once a case appears to be refractory limits both social and personal morbidity of chronic psychosis. However t...
Autores principales: | Voulgari, Christina, Giannas, Raphael, Paterakis, Georgios, Kanellou, Anna, Anagnostopoulos, Nikolaos, Pagoni, Stamata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338390/ https://www.ncbi.nlm.nih.gov/pubmed/25755670 http://dx.doi.org/10.1155/2015/703218 |
Ejemplares similares
-
Clozapine-induced agranulocytosis
por: Mijovic, Aleksandar, et al.
Publicado: (2020) -
AGRANULOCYTOSIS DURING CLOZAPINE THERAPY
por: Jagadheesan, K., et al.
Publicado: (2000) -
Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland
por: Ingimarsson, Oddur, et al.
Publicado: (2016) -
Clozapine rechallenge or continuation despite neutropenia or agranulocytosis using colony-stimulating factor: A systematic review
por: Corbeil, Olivier, et al.
Publicado: (2023) -
Late Onset Clozapine Induced Agranulocytosis
por: Velayudhan, Rajmohan, et al.
Publicado: (2014)